Search results for: “oncology”
-
Windtree Therapeutics acquires Varian Biopharmaceuticals’ assets
•
Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced the acquisition of a novel oncology asset platform from Varian Biopharmaceuticals,…
-
PanTher Therapeutics appoints John Edwards as Executive Chair
•
PanTher Therapeutics, a pioneer in localized cancer treatment, has announced the appointment of John Edwards as the Executive…
-
Alterome Therapeutics raises $132 million in Series B led by Goldman Sachs Alternatives
•
SAN DIEGO: Alterome Therapeutics, Inc., a trailblazer in the biopharmaceutical industry, has successfully completed a Series B financing…
-
Genmab A/S acquires ProfoundBio in a landmark $1.8 billion deal
•
Genmab A/S (Nasdaq: GMAB) has announced the acquisition of ProfoundBio, Inc., a clinical-stage company specializing in advanced antibody-drug…
-
AstraZeneca to acquire Fusion Pharmaceuticals in a $ 2.0 billion deal
•
LONDON: AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing…
-
Zephyr AI Secures $111 million in Series A funding
•
Zephyr AI, Inc. has announced the successful closure of a $111 million Series A funding round. The round…
-
OncoNano Medicine Names Dr. Kartik Krishnan as New CEO
•
OncoNano Medicine, a biotechnology company developing innovative cancer therapies, announced today that Dr. Kartik Krishnan, MD, PhD, has…
-
Fore Biotherapeutics appoints Bill Hinshaw as new CEO
•
Fore Biotherapeutics, a biotech company developing novel cancer therapies, announced today that it has appointed Bill Hinshaw as…
-
Radformation and Icon Group join forces to transform cancer care
•
BRISBANE: Radformation, a leader in radiation oncology software, and Icon Group, a global provider of cancer care, have…
-
AstraZeneca reports strong growth in 2023 despite COVID-19 challenges
•
AstraZeneca, a global biopharmaceutical company, announced its financial results for the full year 2023, showing a 6% increase…
-
Telix Pharmaceuticals signs deal to acquire QSAM Biosciences for upto $123m
•
MELBOURNE, AUSTRALIA: Telix Pharmaceuticals Limited has entered into an agreement to acquire QSAM Biosciences, Inc. and its lead…
-
Jazz Pharmaceuticals acquires Redx’s KRAS inhibitor program
•
Alderley Park, UK: Jazz Pharmaceuticals plc and Redx Pharma plc have signed a definitive agreement under which Jazz…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.